S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study

We investigated the efficacy of S-Adenosyl-L-Methionine (SAMe) augmentation in patients with treatment-resistant depressive disorder (TRD). Thirty-three outpatients with major depressive episode who failed to respond to at least 8 weeks of treatment with two adequate and stable doses of antidepressa...

Descripción completa

Detalles Bibliográficos
Autores principales: De Berardis, Domenico, Marini, Stefano, Serroni, Nicola, Rapini, Gabriella, Iasevoli, Felice, Valchera, Alessandro, Signorelli, Maria, Aguglia, Eugenio, Perna, Giampaolo, Salone, Anatolia, Di Iorio, Giuseppe, Martinotti, Giovanni, Di Giannantonio, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666233/
https://www.ncbi.nlm.nih.gov/pubmed/23766680
http://dx.doi.org/10.1155/2013/204649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666233/
https://www.ncbi.nlm.nih.gov/pubmed/23766680
http://dx.doi.org/10.1155/2013/204649

Ejemplares similares